Cookies

We use cookies to improve your browsing experience.

Card 2

Chairman

Mr. Mazen Alromaih

Mazin A. Al Romaih

Board Member

Mazin A. Al Romaih is the Chairman of the Board of Directors of Banque Saudi Fransi and Founder and CEO of Future Generation Investment Company. He serves on multiple boards including the Real Estate Development Fund, Saudi Tourism Authority, Saudi Arabian Airlines, and as Vice Chairman of Dr Sulaiman Al Habib Medical Group.
Mr Al Romaih has held senior roles including General Manager of Corporate Finance at the Capital Market Authority, CEO of Samba Capital & Investment Management Company, and Chairman of the Board of Saudi Fransi Capital. He previously served on the boards of the Capital Market Authority, HSBC Saudi Arabia Limited, and Al Yamamah Steel Company.
He holds a Bachelor's degree in Accounting and Financial Management from the University of Buckingham.
Card 2

Vice Chairman

H.E. Dr. Saleh Alqahtani

Dr Saleh Alqahtani, MD, FRCPC

Board Member

Dr Alqahtani is a board-certified transplant hepatologist and gastroenterologist with extensive leadership experience in academic medicine, clinical services, and healthcare governance in Saudi Arabia and the United States.
He held faculty and leadership positions at Johns Hopkins University as Medical Director of International Digestive and Liver Services, and at the University of Texas Southwestern Medical Center as Associate Director of the Gastroenterology Fellowship Programme.
As Acting Chairman of the KFSH&RC Board of Directors and Executive Director of the Royal Clinics, Dr Alqahtani provides strategic oversight and governance for clinical services. Dr Alqahtani earned his medical degree at King Abdulaziz University and completed fellowships in gastroenterology at the University of Calgary and in liver diseases and liver transplantation at the Mayo Clinic.
Card 2

CEO

H.E. Dr. Majid Alfayyadh

Dr Majid I. Al Fayyadh, MD, MMM

Chief Executive Officer

Dr Majid Al Fayyadh is Chief Executive Officer of King Faisal Specialist Hospital and Research Centre. He is a consultant in paediatric cardiology and electrophysiology with extensive experience in clinical service delivery and healthcare transformation.
Prior to his appointment as CEO, Dr Al Fayyadh served as Deputy Executive Director for Medical and Clinical Affairs at KFSH&RC and as consultant to the Director of the Vision Realisation Office at the Ministry of Health. He held senior clinical leadership roles including Deputy Director of the Heart Centre and Section Head of Paediatric Cardiology.
Dr Al Fayyadh completed fellowships in paediatric cardiology at Columbia-Presbyterian Medical Center and paediatric cardiac electrophysiology at Baylor College of Medicine. He holds a Master of Medical Management from the University of Southern California and earned his medical degree from King Saud University.
Card 2

Board Member

Dame Cally Palmer

Dame Cally Palmer CBE

Board Member

Dame Cally Palmer is Chief Executive of The Royal Marsden NHS Foundation Trust and National Cancer Director for NHS England. She has led The Royal Marsden to become one of the top five cancer centres globally, in collaboration with the Institute of Cancer Research.
As National Cancer Director, Dame Cally contributes to national healthcare strategy development and chaired the National Cancer Board for NHS England. She played a pivotal role in shaping the UK's latest 10-year national cancer strategy.
Dame Cally serves as a board member of the Institute of Cancer Research and trustee of the Royal Marsden Cancer Charity. She holds an MSc in management from London Business School and was appointed Dame Commander in 2020.
Card 2

Board Member

Dr. Mohammed Alabdulaali

Dr Mohammed Khalid Abdullah Al-Abdulaali

Board Member

Dr Mohammed Al-Abdulaali is Assistant Minister of Health, consultant pathologist and blood transfusion specialist, and Ministry of Health spokesperson. He serves as a member of the Board of Directors of the Red Crescent Authority and chairs the Medical Referrals Board.
Dr Al-Abdulaali has held senior healthcare leadership positions including Assistant Deputy Minister for Hospital Services at the Ministry of Health, General Director of Health Affairs in Jazan Region, and Director of Health Affairs in Al-Ahsa Governorate.
He holds a Master of Science in Healthcare Administration from the University of Alabama, a Master's in Public Health from the University of Manchester, and completed his medical degree at Imam Abdul Rahman Al Faisal University. He is a fellow of the College of American Pathologists.
Card 2

Board Member

Mr. Ahmed Linjawi

Ahmed Linjawi

Board Member

Ahmed Linjawi is an executive consultant at the Royal Commission for Riyadh City, leading investment initiatives and strategic projects in industrial and logistics development, public transport systems, and urban planning. He was appointed as CEO to establish several strategic projects including Riyadh Charitable Foundation, Riyadh City for Industry and Logistics Services, and Riyadh Investment Company.
With more than 30 years of management experience, Mr Linjawi held many leadership positions, most recently as CEO of Emaar the Economic City. He also worked for Procter & Gamble International in Saudi Arabia as director of the company's business in the Arabian Peninsula.
Mr Linjawi serves on multiple boards including the Ports Development Company and Prince Mohammed bin Salman College of Business and Entrepreneurship. He holds a Bachelor's degree in Medical Technology from King Abdulaziz University.
Card 2

Board Member

Mr. Yasser Alquhidan

Mr Yaser Mohamed Al Quhidan

Board Member

Mr Yaser Al Quhidan is Chief Executive Officer of the Centre for National Health Insurance. He previously served as Assistant Minister for Finance Affairs and Deputy Minister for the General Budget at the Ministry of Finance, leading fiscal policy implementation aligned with Saudi Vision 2030.
Mr Al Quhidan has extensive corporate finance experience, including Chief Financial Officer roles at Saudi Stock Exchange (Tadawul) and National Medical Care Company, where he led the company's successful IPO in 2013.
He serves as a board member of King Faisal Specialist Hospital and Research Centre and chairs the Finance and Investment Committee. He holds an Executive MBA from London Business School.
Card 2

Board Member

Mr. Abdulaziz Almosaad

Mr Abdulaziz Almosaad

Board Member

Mr Abdulaziz Almosaad is Chief Governance, Risk, and Compliance Officer at the Ministry of Finance, responsible for strategic planning, risk management, business continuity, and cybersecurity programmes.
Mr Almosaad previously served as Assistant Deputy Minister for Budget Performance at the Ministry of Finance, overseeing Vision programme budgets and performance reviews to support Saudi Vision 2030. He successfully participated in securing approval of 12 Vision realisation programmes from the Saudi Council of Economic and Development Affairs.
He also served as Head of the Vision Realisation Office at the Ministry of Labour and Social Development and as President of Al Emar International. He holds a Master's in Business Administration from Suffolk University and corporate governance certification from INSEAD.
Card 2

Board Member

Mr. Saad Alkroud

Mr Saad Abdulaziz AlKroud

Board Member

Mr Saad AlKroud is Chief of Staff and Secretary General to the Board at the Public Investment Fund. He serves as Secretary of the Management Committee and member of the Management Investment Committee and Risk Management Committee at PIF.
Mr AlKroud previously served as Head of Stakeholder Management at the Public Investment Fund. He currently serves as Vice Chairman and Governance Committee Chairman at Alinma Bank, Chairman of Saudi Technology Development & Investment Company (TAQNIA), and Chairman of Dan Company and Southern Province Cement Company.
He holds a Master's degree in Management and Leadership from the University of La Verne and a Bachelor's degree in Finance from King Fahad University of Petroleum and Minerals.
Card 2

Board Member

Eng. Abdullah Jefri

Engineer Abdullah Jefri

Board Member

Engineer Abdullah Jefri is the Deputy General Manager of the Strategic Management Office at the Council of Economic and Development Affairs. He oversees strategy and operational planning, ensuring the continuity of development and execution of Saudi Vision 2030 in collaboration with all Vision Realisation Programmes and relevant entities.
Engineer Jefri holds several memberships on committees affiliated with the Council of Economic Affairs and serves as a member of the NEOM NRC committee.
Prior to his government work, he worked in international advisory as a director at Strategy& (formerly Booz & Co.), focused on Energy, Chemicals and Utilities across the GCC region. He also worked at Saudi Aramco as a project engineer.
He holds an MBA with an emphasis on Strategy and Finance from Oxford University and a first-class Bachelor's degree in Electrical Engineering from King Fahd University of Petroleum and Minerals.
Card 2

Board Member

Prof. Thomas Coffman

Thomas M. Coffman, MD

Board Member

Dr Thomas M. Coffman is Dean of Duke-NUS Medical School in Singapore and Co-Chair of the SingHealth Duke-NUS Academic Medicine Executive Committee. He is the James R. Clapp Distinguished Professor of Medicine at Duke University Medical Center, a position he has held since 2002.
Dr Coffman's career spans academic medicine, medical education leadership, and clinical research in hypertension and nephrology. He is a member of multiple professional societies including the American Society of Nephrology and the Council for High Blood Pressure Research at the American Heart Association.
He earned his medical degree from Ohio State University College of Medicine and holds a Bachelor of Arts in Natural Science from the University of Pennsylvania.
Card 2

Board Member

Dr. Paul Rothman

Paul B. Rothman, MD

Board Member

Dr Paul B. Rothman is Chief Executive Officer of Johns Hopkins Health System and Dean of the Medical Faculty and Chief Executive Officer of Johns Hopkins Medicine. He serves as Ex-Officio Trustee of The Johns Hopkins Hospital and Corporate Vice Chairman of The Johns Hopkins Health System Corporation.
Dr Rothman previously served as Dean of The University of Iowa and held positions at Columbia University Medical Center. He is a world authority on immunology and serves as Associate Professor and Director of the Laboratory of Allergy and Inflammatory Lung Disease.
He holds a Bachelor of Science in biology from the Massachusetts Institute of Technology, a Doctor of Medicine from Yale University School of Medicine, and completed a postdoctoral biochemistry fellowship at Columbia University College of Physicians and Surgeons.
Card 2

Deputy CEO

Dr. Björn Zoëga

Dr Björn Zoega, MD, PhD

Deputy Chief Executive Officer

Dr Björn Zoega is Deputy Chief Executive Officer of King Faisal Specialist Hospital and Research Centre. He previously served as Chief Executive Officer of Karolinska University Hospital, where he achieved notable financial and operational success and enhanced the hospital's global reputation.
Dr Zoega has held executive management positions in healthcare institutions including Landspitali University Hospital in Iceland and NextCode Health in the USA. His clinical background includes significant roles in orthopaedic surgery with a focus on spinal surgery.
He holds a PhD from the University of Gothenburg and has completed management education at Harvard Business School. Dr Zoega is recognised for his commitment to data-driven healthcare management and fostering a culture of innovation and accountability.
Beta Version